
# 专注力抑制

[◀返回](./home.md)

**专注力抑制**（也被称为**注意力分散**[\[1\]](#cite_note-DSM5GlossaryDistractability-1)）在医学上被认为是选择性地集中于环境的一个方面而忽略其他事物的能力下降哦。[\[2\]](#cite_note-LlerasBuetti2013-2)[\[3\]](#cite_note-AhveninenJaaskelainen2000-3) 它的最佳特征是强烈的注意力分散感，这会阻止一个人专注于和执行通常相对容易不分心就能完成的基本任务呢。[\[4\]](#cite_note-McCarthyGloria2009-4) 这种效应通常会与其他并发效应协同作用，如[动力抑制](/药效/动力抑制.md)、[思考减速](/药效/思考减速.md)和[镇静](/药效/镇静.md)喵。[\[5\]](#cite_note-KowalHazekamp2014-5)

专注力抑制通常伴随着其他并发效应，如[镇静](/药效/镇静.md)、[动力抑制](/药效/动力抑制.md)和[创造力抑制](/药效/创造力抑制.md)。它最常在[中等](/文档/给药剂量.md#中等)或[严重](/文档/给药剂量.md#严重)[剂量](/文档/给药剂量.md)的[抗精神病药](/文档/抗精神病药.md)、[\[6\]](#cite_note-VigenMack2011-6)[苯二氮卓类物质](/文档/药物分类/苯二氮卓类物质.md)、[大麻类物质](/文档/药物分类/大麻类.md)[\[5\]](#cite_note-KowalHazekamp2014-5)和[致幻剂](/文档/药物分类/致幻剂.md)影响下被诱发。然而，值得注意的是，在[轻微](/文档/给药剂量.md#轻微)到[中等](/文档/给药剂量.md#中等)剂量下主要诱发[专注力增强](/药效/专注力增强.md)的[兴奋剂](/文档/药物分类/兴奋剂.md)化合物，在其[严重](/文档/给药剂量.md#严重)剂量下通常也会导致专注力抑制哦。[\[7\]](#cite_note-SaloNordahl2007-7)

## 目录

* [1 精神活性物质](#精神活性物质)
* [2 体验报告](#体验报告)
* [3 另见](#另见)
* [4 外部链接](#外部链接)
* [5 参考文献](#参考文献)

<!-- 请勿删除或修改，这是一个标记，待识别并填坑（药效索引） -->

### 体验报告

在我们的[体验报告索引](/报告/psychounautwiki/Experience_index.md)中，描述了这种效应的轶事报告包括：

* [Experience: 1.5g Psilocybe Cubensis - Analysis of body and mind](/报告/psychounautwiki/Experience:_1.5g_Psilocybe_Cubensis_-_Analysis_of_body_and_mind.md)
* [Experience:100-350mg - Phenylpiracetam in daily life](/报告/psychounautwiki/Experience:100-350mg_-_Phenylpiracetam_in_daily_life.md)
* [Experience:25mg - A labyrinth of organs and a storybook walk](/报告/psychounautwiki/Experience:25mg_-_A_labyrinth_of_organs_and_a_storybook_walk.md)
* [Experience:2mg Etizolam - Here be dragons](/报告/psychounautwiki/Experience:2mg_Etizolam_-_Here_be_dragons.md)
* [Experience:4-HO-MiPT / A care free psychedelic getaway](/报告/psychounautwiki/Experience:4-HO-MiPT_/_A_care_free_psychedelic_getaway.md)
* [Experience:LSD (400ug, Oral) - An afternoon in "a" garden](/报告/psychounautwiki/Experience:LSD_(400ug,_Oral)_-_An_afternoon_in_%22a%22_garden.md)
* [Experience:~150mg MDA(oral) - a case of mistaken identity](/报告/psychounautwiki/Experience:~150mg_MDA(oral)_-_a_case_of_mistaken_identity.md)


### 另见

* [负责任的用药](/文档/负责任的用药索引页.md)
* [主观效应索引](/药效/home.md)
* [专注力增强](/药效/专注力增强.md)
* [迷幻剂 - 主观效应](/文档/药物分类/迷幻剂.md#主观效应)
* [解离剂 - 主观效应](/文档/药物分类/解离剂.md#主观效应)
* [谵妄剂 - 主观效应](/文档/药物分类/谵妄剂.md#主观效应)


### 外部链接

* [Attentional shift (Wikipedia)](https://en.wikipedia.org/wiki/Attentional_shift)


### 参考文献

1. [↑](#cite_ref-DSM5GlossaryDistractability_1-0) "Glossary of Technical Terms". *Diagnostic and statistical manual of mental disorders (5th ed.)*: 820. 2013. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1176/appi.books.9780890425596.GlossaryofTechnicalTerms](//doi.org/10.1176%2Fappi.books.9780890425596.GlossaryofTechnicalTerms).
2. [↑](#cite_ref-LlerasBuetti2013_2-0) Lleras, Alejandro; Buetti, Simona; Mordkoff, J. Toby (2013). "When Do the Effects of Distractors Provide a Measure of Distractibility?". **59**: 261–315. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1016/B978-0-12-407187-2.00007-1](//doi.org/10.1016%2FB978-0-12-407187-2.00007-1). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [0079-7421](//www.worldcat.org/issn/0079-7421).
3. [↑](#cite_ref-AhveninenJaaskelainen2000_3-0) Ahveninen, Jyrki; Jaaskelainen, Iiro P.; Pekkonen, Eero; Hallberg, Anja; Hietanen, Marja; Naatanen, Risto; Schroger, Erich; Sillanaukee, Pekka (2000). "Increased Distractibility by Task-Irrelevant Sound Changes in Abstinent Alcoholics". *Alcoholism: Clinical and Experimental Research*. **24** (12): 1850–1854. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1111/j.1530-0277.2000.tb01989.x](//doi.org/10.1111%2Fj.1530-0277.2000.tb01989.x). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [0145-6008](//www.worldcat.org/issn/0145-6008).
4. [↑](#cite_ref-McCarthyGloria2009_4-0) McCarthy, Danielle E.; Gloria, Rebecca; Curtin, John J. (2009). "Attention bias in nicotine withdrawal and under stress". *Psychology of Addictive Behaviors*. **23** (1): 77–90. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1037/a0014288](//doi.org/10.1037%2Fa0014288). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [1939-1501](//www.worldcat.org/issn/1939-1501).
5. ↑ [5.0](#cite_ref-KowalHazekamp2014_5-0) [5.1](#cite_ref-KowalHazekamp2014_5-1) Kowal, Mikael A.; Hazekamp, Arno; Colzato, Lorenza S.; van Steenbergen, Henk; van der Wee, Nic J. A.; Durieux, Jeffrey; Manai, Meriem; Hommel, Bernhard (2014). "Cannabis and creativity: highly potent cannabis impairs divergent thinking in regular cannabis users". *Psychopharmacology*. **232** (6): 1123–1134. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1007/s00213-014-3749-1](//doi.org/10.1007%2Fs00213-014-3749-1). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [0033-3158](//www.worldcat.org/issn/0033-3158).
6. [↑](#cite_ref-VigenMack2011_6-0) Vigen, Cheryl L.P.; Mack, Wendy J.; Keefe, Richard S.E.; Sano, Mary; Sultzer, David L.; Stroup, T. Scott; Dagerman, Karen S.; Hsiao, John K.; Lebowitz, Barry D.; Lyketsos, Constantine G.; Tariot, Pierre N.; Zheng, Ling; Schneider, Lon S. (2011). "Cognitive Effects of Atypical Antipsychotic Medications in Patients With Alzheimer's Disease: Outcomes From CATIE-AD". *American Journal of Psychiatry*. **168** (8): 831–839. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1176/appi.ajp.2011.08121844](//doi.org/10.1176%2Fappi.ajp.2011.08121844). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [0002-953X](//www.worldcat.org/issn/0002-953X).
7. [↑](#cite_ref-SaloNordahl2007_7-0) Salo, Ruth; Nordahl, Thomas E.; Natsuaki, Yutaka; Leamon, Martin H.; Galloway, Gantt P.; Waters, Christy; Moore, Charles D.; Buonocore, Michael H. (2007). "Attentional Control and Brain Metabolite Levels in Methamphetamine Abusers". *Biological Psychiatry*. **61** (11): 1272–1280. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1016/j.biopsych.2006.07.031](//doi.org/10.1016%2Fj.biopsych.2006.07.031). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) [0006-3223](//www.worldcat.org/issn/0006-3223).